AIM2 and gastric adenocarcinoma: Coupled with the finding that AIM2 can also act independent of inflammasomes to promote later stage gastric adenocarcinoma, these observations expand our current understanding of the complexities of AIM2 function during the cascade of events and immunoregulatory checkpoints that underpin gastric carcinogenesis.